New Publication: NCCN Guidelines for LCH, ECD, Rosai-Dorfman Disease
Free-Photos / Pixabay

New Publication: NCCN Guidelines for LCH, ECD, Rosai-Dorfman Disease

In early March 2021, the National Comprehensive Cancer Network (NCCN) shared a new set of NCCN Guidelines for Histiocytosis. Histiocytosis, or hystiocytic disorders, are a group of rare conditions characterized…

Continue Reading New Publication: NCCN Guidelines for LCH, ECD, Rosai-Dorfman Disease

New Device Could Help Langerhans Cell Histiocytosis Patients Monitor Their Own Chemotherapy Treatments

Langerhans Cell Histiocystosis Langerhans Cell Histiocytosis (LCH) Is a rare form of cancer caused by an excessive amount of Langerhan cells in the body. These cells form granulomas which can have a…

Continue Reading New Device Could Help Langerhans Cell Histiocytosis Patients Monitor Their Own Chemotherapy Treatments